Skip to main content

CVA Family Office, LLC

Family Office

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1802084 DENVER, CO

Position in REGN

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$149,892
+$37,971 QoQ
Shares Held
194
+33.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CVA Family Office, LLC holds $673,464 across 40 Biotechnology names. REGN ranks #2 (22.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
194 $149,892

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $149,892 194
2025-12-31 $111,921 145
2025-09-30 $84,340 150
2025-06-30 $73,500 140
2025-03-31 $104,647 165
2024-12-31 $109,698 154
2024-09-30 $152,429 145
2024-06-30 $146,093 139
2024-03-31 $132,823 138
2023-12-31 $120,325 137
2023-06-30 $88,380 123
2023-03-31 $101,065 123
2022-12-31 $86,578 120
2022-09-30 $79,220 115
2022-06-30 $56,157 95
2022-03-31 $101,270 145
2021-12-31 $59,994 95
2021-06-30 $53,061 95
2021-03-31 $33,119 70